| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 2.01e-06 | 4 | 160 | 3 | GO:0071614 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 3.73e-06 | 14 | 160 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.75e-05 | 8 | 160 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.75e-05 | 8 | 160 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 3.72e-05 | 24 | 160 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 4.57e-05 | 431 | 160 | 13 | GO:0004984 |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 5.41e-05 | 164 | 160 | 8 | GO:0046906 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 6.03e-05 | 27 | 160 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 6.38e-05 | 2 | 160 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | selenide, water dikinase activity | 6.38e-05 | 2 | 160 | 2 | GO:0004756 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, paired acceptors | 6.38e-05 | 2 | 160 | 2 | GO:0016781 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 6.38e-05 | 2 | 160 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 6.38e-05 | 2 | 160 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 6.38e-05 | 2 | 160 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIM49 CYP2C19 CYP2C8 CYP2C9 CYP2C18 MIOX ADAMTS3 ADAMTS2 NEIL1 TRIM49C OR4E2 TRIM27 ZZEF1 GSTM1 APIP KAT7 SMPDL3B MTR KDM4A NR3C2 KDM7A TRIM49B NOS1 | 7.66e-05 | 1189 | 160 | 23 | GO:0046914 |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 7.95e-05 | 11 | 160 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.71e-04 | 35 | 160 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 2.14e-04 | 15 | 160 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.30e-04 | 115 | 160 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 3.79e-04 | 4 | 160 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 5.87e-04 | 48 | 160 | 4 | GO:0032266 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 6.28e-04 | 5 | 160 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 6.28e-04 | 5 | 160 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 6.28e-04 | 5 | 160 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.35e-04 | 49 | 160 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 9.79e-04 | 194 | 160 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | cAMP binding | 1.02e-03 | 25 | 160 | 3 | GO:0030552 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | HGD CYP2C19 CYP2C8 CYP2C9 CYP2C18 MIOX MTHFD2 ALDH8A1 CAT OGDH RDH11 DHRS9 KDM4A KDM7A NOS1 | 1.29e-03 | 766 | 160 | 15 | GO:0016491 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DCAF1 HK2 CDKL2 POLD1 CDS2 OBSCN CMPK2 RYK EDNRA NMNAT3 SEPHS2 SEPHS1 SPHK1 GUCY2D AKT1 FGFR3 HSPB8 | 1.43e-03 | 938 | 160 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | heme binding | 1.53e-03 | 154 | 160 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 1.73e-03 | 8 | 160 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 GRM5 EDNRA OR13D1 OR13C9 OR11H1 SPHK1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 2.00e-03 | 884 | 160 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | zinc ion binding | TRIM49 ADAMTS3 ADAMTS2 NEIL1 TRIM49C TRIM27 ZZEF1 APIP KAT7 SMPDL3B MTR KDM4A NR3C2 KDM7A TRIM49B NOS1 | 2.17e-03 | 891 | 160 | 16 | GO:0008270 |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 2.21e-03 | 9 | 160 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.23e-03 | 166 | 160 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.31e-03 | 33 | 160 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.41e-03 | 70 | 160 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 2.52e-03 | 34 | 160 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.62e-03 | 118 | 160 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 2.75e-03 | 10 | 160 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | cobalamin binding | 2.75e-03 | 10 | 160 | 2 | GO:0031419 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | HGD CYP2C19 CYP2C8 CYP2C9 HK2 GLS2 BCAS3 WASHC1 ALDH8A1 AMDHD1 CAT KEAP1 MCCC1 CUBN TRIM27 KYAT1 GSTM1 UGT1A1 WASH3P SMPDL3B SPHK1 AKT1 ZFYVE26 KDM4A POLDIP2 PLD1 NOS1 HSPB8 | 3.29e-07 | 1253 | 159 | 28 | GO:0044248 |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 3.64e-07 | 37 | 159 | 6 | GO:0042178 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | HGD GLS2 ALDH8A1 AMDHD1 MCCC1 KYAT1 APIP SEPHS2 SEPHS1 MTR NOS1 | 6.61e-07 | 208 | 159 | 11 | GO:0170033 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | HGD CYP2C19 CYP2C8 CYP2C9 CYP2C18 HK2 GLS2 MTHFD2 ALDH8A1 AMDHD1 MCCC1 OGDH KYAT1 GSTM1 UGT1A1 APIP SEPHS2 SEPHS1 SPHK1 DHRS9 MTR INSIG2 AKT1 NOS1 | 1.34e-06 | 1035 | 159 | 24 | GO:0019752 |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.55e-06 | 105 | 159 | 8 | GO:0006721 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | CYP2C19 CYP2C8 CYP2C9 CYP2C18 ALDH8A1 UGT1A1 RDH11 DHRS9 ALG12 | 1.79e-06 | 144 | 159 | 9 | GO:0006720 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | HGD CYP2C19 CYP2C8 CYP2C9 CYP2C18 HK2 GLS2 MTHFD2 ALDH8A1 AMDHD1 MCCC1 OGDH KYAT1 GSTM1 UGT1A1 APIP SEPHS2 SEPHS1 SPHK1 DHRS9 MTR INSIG2 AKT1 NOS1 | 1.97e-06 | 1058 | 159 | 24 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | HGD CYP2C19 CYP2C8 CYP2C9 CYP2C18 HK2 GLS2 MTHFD2 ALDH8A1 AMDHD1 MCCC1 OGDH KYAT1 GSTM1 UGT1A1 APIP SEPHS2 SEPHS1 SPHK1 DHRS9 MTR INSIG2 AKT1 NOS1 | 2.18e-06 | 1064 | 159 | 24 | GO:0006082 |
| GeneOntologyBiologicalProcess | L-amino acid catabolic process | 2.81e-06 | 80 | 159 | 7 | GO:0170035 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | HGD GLS2 ALDH8A1 AMDHD1 MCCC1 KYAT1 APIP SEPHS2 SEPHS1 MTR NOS1 | 4.12e-06 | 251 | 159 | 11 | GO:1901605 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR1M1 PDC OR4S2 OR13C3 OR13C4 CDS2 OR4E2 OR13D1 OR13C9 PKD2L2 OR11H1 GUCY2D OR13C2 CRTAM OR10S1 OR7G3 OR11H2 OR7A10 | 1.21e-05 | 722 | 159 | 18 | GO:0051606 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.35e-05 | 40 | 159 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 1.39e-05 | 185 | 159 | 9 | GO:0170039 | |
| GeneOntologyBiologicalProcess | alpha-amino acid catabolic process | 1.61e-05 | 104 | 159 | 7 | GO:1901606 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 2.23e-05 | 22 | 159 | 4 | GO:0019373 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 3.15e-05 | 432 | 159 | 13 | GO:0050911 |
| GeneOntologyBiologicalProcess | endosome to plasma membrane protein transport | 3.20e-05 | 24 | 159 | 4 | GO:0099638 | |
| GeneOntologyBiologicalProcess | amino acid catabolic process | 3.46e-05 | 117 | 159 | 7 | GO:0009063 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | CYP2C8 CYP2C9 GLS2 ALDH8A1 GSTM1 APIP SEPHS2 SEPHS1 SPHK1 DHRS9 MTR INSIG2 | 3.46e-05 | 374 | 159 | 12 | GO:0046394 |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | CYP2C8 CYP2C9 GLS2 ALDH8A1 GSTM1 APIP SEPHS2 SEPHS1 SPHK1 DHRS9 MTR INSIG2 | 3.74e-05 | 377 | 159 | 12 | GO:0016053 |
| GeneOntologyBiologicalProcess | amino acid metabolic process | HGD GLS2 ALDH8A1 AMDHD1 MCCC1 KYAT1 APIP SEPHS2 SEPHS1 MTR NOS1 | 5.54e-05 | 332 | 159 | 11 | GO:0006520 |
| GeneOntologyBiologicalProcess | selenocysteine biosynthetic process | 5.91e-05 | 2 | 159 | 2 | GO:0016260 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 6.55e-05 | 89 | 159 | 6 | GO:0001523 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 6.69e-05 | 465 | 159 | 13 | GO:0007608 |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 7.96e-05 | 180 | 159 | 8 | GO:0120254 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 7.97e-05 | 30 | 159 | 4 | GO:0072012 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 8.89e-05 | 94 | 159 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 9.10e-05 | 31 | 159 | 4 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 9.10e-05 | 31 | 159 | 4 | GO:0061437 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 1.02e-04 | 485 | 159 | 13 | GO:0050907 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.13e-04 | 141 | 159 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.54e-04 | 14 | 159 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP2C19 CYP2C8 CYP2C9 CYP2C18 HK2 ALDH8A1 AMDHD1 MCCC1 OGDH KYAT1 GSTM1 UGT1A1 SPHK1 DHRS9 INSIG2 AKT1 | 1.73e-04 | 731 | 159 | 16 | GO:0032787 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR1M1 PDC OR4S2 OR13C3 OR13C4 OR4E2 GRM5 ITGB1 RGS2 EDNRA OR13D1 OR13C9 OR11H1 SPHK1 GUCY2D OR13C2 AKT1 NR3C2 PARD3 OR10S1 OR7G3 OR11H2 OR7A10 NOS1 | 1.76e-04 | 1395 | 159 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | glomerular endothelium development | 1.76e-04 | 3 | 159 | 2 | GO:0072011 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.80e-04 | 68 | 159 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.84e-04 | 37 | 159 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 1.93e-04 | 69 | 159 | 5 | GO:0170038 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 2.07e-04 | 70 | 159 | 5 | GO:0170034 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 2.18e-04 | 524 | 159 | 13 | GO:0009593 |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 2.33e-04 | 112 | 159 | 6 | GO:0010507 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid catabolic process | 2.86e-04 | 75 | 159 | 5 | GO:0170040 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 3.23e-04 | 77 | 159 | 5 | GO:1901607 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 3.30e-04 | 547 | 159 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | L-kynurenine catabolic process | 3.51e-04 | 4 | 159 | 2 | GO:0097053 | |
| GeneOntologyBiologicalProcess | selenocysteine metabolic process | 3.51e-04 | 4 | 159 | 2 | GO:0016259 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | CYP2C8 CYP2C9 CYP2C18 MIOX CAT CUBN RDH11 SPHK1 DHRS9 INSIG2 ALG12 | 3.64e-04 | 412 | 159 | 11 | GO:0006066 |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 3.64e-04 | 79 | 159 | 5 | GO:0034394 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | RELN CYP2C8 CYP2C9 CYP2C18 ALDH8A1 SLCO4A1 UGT1A1 RDH11 DHRS9 | 3.88e-04 | 286 | 159 | 9 | GO:0042445 |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 4.03e-04 | 124 | 159 | 6 | GO:0001676 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 4.36e-04 | 421 | 159 | 11 | GO:0044282 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | RELN CYP2C8 CYP2C9 CYP2C18 MIOX SLCO4A1 CAT CUBN EDNRA RDH11 SPHK1 DHRS9 INSIG2 ALG12 | 4.55e-04 | 641 | 159 | 14 | GO:1901615 |
| GeneOntologyBiologicalProcess | oocyte maturation | 4.69e-04 | 47 | 159 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | maintenance of protein localization in organelle | 4.69e-04 | 47 | 159 | 4 | GO:0072595 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 4.78e-04 | 128 | 159 | 6 | GO:0033559 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 5.38e-04 | 86 | 159 | 5 | GO:0008652 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear receptor cell differentiation | 5.82e-04 | 5 | 159 | 2 | GO:2000981 | |
| GeneOntologyBiologicalProcess | error-free translesion synthesis | 5.82e-04 | 5 | 159 | 2 | GO:0070987 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in mitochondrion | 5.82e-04 | 5 | 159 | 2 | GO:0072656 | |
| GeneOntologyBiologicalProcess | negative regulation of inner ear auditory receptor cell differentiation | 5.82e-04 | 5 | 159 | 2 | GO:0045608 | |
| GeneOntologyBiologicalProcess | negative regulation of mechanoreceptor differentiation | 5.82e-04 | 5 | 159 | 2 | GO:0045632 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 5.92e-04 | 582 | 159 | 13 | GO:0050906 |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell surface | 6.41e-04 | 51 | 159 | 4 | GO:2000008 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 7.11e-04 | 23 | 159 | 3 | GO:0043651 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 7.42e-04 | 53 | 159 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | demethylation | 8.08e-04 | 24 | 159 | 3 | GO:0070988 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 8.25e-04 | 142 | 159 | 6 | GO:0006690 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 8.68e-04 | 6 | 159 | 2 | GO:0016098 | |
| GeneOntologyBiologicalProcess | 9-cis-retinoic acid biosynthetic process | 8.68e-04 | 6 | 159 | 2 | GO:0042904 | |
| GeneOntologyBiologicalProcess | 9-cis-retinoic acid metabolic process | 8.68e-04 | 6 | 159 | 2 | GO:0042905 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 8.68e-04 | 6 | 159 | 2 | GO:1904109 | |
| Domain | Olfact_rcpt | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 3.50e-05 | 393 | 160 | 13 | IPR000725 |
| Domain | SPS/SelD | 7.29e-05 | 2 | 160 | 2 | IPR004536 | |
| Domain | - | 2.18e-04 | 3 | 160 | 2 | 3.90.650.10 | |
| Domain | Ion_trans_N | 4.33e-04 | 4 | 160 | 2 | IPR013621 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 3.30.1330.10 | |
| Domain | Ion_trans_N | 4.33e-04 | 4 | 160 | 2 | PF08412 | |
| Domain | AIRS_C | 4.33e-04 | 4 | 160 | 2 | PF02769 | |
| Domain | AIRS | 4.33e-04 | 4 | 160 | 2 | PF00586 | |
| Domain | PurM-like_N | 4.33e-04 | 4 | 160 | 2 | IPR016188 | |
| Domain | AIR_synth_C_dom | 4.33e-04 | 4 | 160 | 2 | IPR010918 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.74e-06 | 64 | 128 | 7 | M9488 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR1M1 PDC OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 GUCY2D OR13C2 OR10S1 OR7G3 OR7A10 | 1.18e-05 | 389 | 128 | 14 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 RDH11 GUCY2D DHRS9 OR13C2 GPC5 BSN OR10S1 OR7G3 OR11H2 OR7A10 | 1.72e-05 | 636 | 128 | 18 | M41834 |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 3.96e-05 | 8 | 128 | 3 | M27135 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.06e-05 | 70 | 128 | 6 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.77e-05 | 72 | 128 | 6 | M9257 | |
| Pathway | REACTOME_XENOBIOTICS | 5.02e-05 | 23 | 128 | 4 | M5372 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 5.90e-05 | 9 | 128 | 3 | M27143 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 1.07e-04 | 417 | 128 | 13 | M4072 |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.14e-04 | 11 | 128 | 3 | M27130 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 1.29e-04 | 29 | 128 | 4 | M2920 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 1.52e-04 | 12 | 128 | 3 | M48064 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 2.47e-04 | 14 | 128 | 3 | MM15842 | |
| Pubmed | 4.54e-10 | 4 | 162 | 4 | 19706858 | ||
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 4.54e-10 | 4 | 162 | 4 | 7704034 | |
| Pubmed | 4.54e-10 | 4 | 162 | 4 | 2009263 | ||
| Pubmed | 4.54e-10 | 4 | 162 | 4 | 21798861 | ||
| Pubmed | 4.54e-10 | 4 | 162 | 4 | 23755828 | ||
| Pubmed | 3.13e-08 | 8 | 162 | 4 | 20430047 | ||
| Pubmed | 9.32e-08 | 10 | 162 | 4 | 18240903 | ||
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 9.92e-08 | 3 | 162 | 3 | 10704292 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 35134542 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 28687336 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 21173785 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 15102943 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 24430292 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 27803446 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 9.92e-08 | 3 | 162 | 3 | 19954515 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8095407 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 9.92e-08 | 3 | 162 | 3 | 21977947 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 23118231 | ||
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 9.92e-08 | 3 | 162 | 3 | 8530044 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 20665013 | ||
| Pubmed | 1.78e-07 | 179 | 162 | 9 | 19074885 | ||
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 2.18e-07 | 12 | 162 | 4 | 12906860 | |
| Pubmed | 2.67e-07 | 30 | 162 | 5 | 20529763 | ||
| Pubmed | 3.14e-07 | 13 | 162 | 4 | 16771603 | ||
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 3.95e-07 | 4 | 162 | 3 | 16025294 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 28990182 | ||
| Pubmed | 4.38e-07 | 14 | 162 | 4 | 20970553 | ||
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 4.38e-07 | 14 | 162 | 4 | 19290787 | |
| Pubmed | Association of warfarin dose with genes involved in its action and metabolism. | 7.90e-07 | 16 | 162 | 4 | 17048007 | |
| Pubmed | 7.90e-07 | 16 | 162 | 4 | 20136364 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 19415824 | ||
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 9.85e-07 | 5 | 162 | 3 | 20857895 | |
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 9.85e-07 | 5 | 162 | 3 | 11701968 | |
| Pubmed | 1.03e-06 | 17 | 162 | 4 | 19424794 | ||
| Pubmed | DCAF1 MTHFD2 POLD1 KEAP1 TRIM27 ZZEF1 TTC7A KAT7 MSH6 THADA RASAL3 BRD7 MTR POLDIP2 PLD1 OSMR PARD3 KAT6B PTCD3 | 1.24e-06 | 1116 | 162 | 19 | 31753913 | |
| Pubmed | OR1M1 OR4S2 OR13C3 OR13C4 OR4E2 OR13D1 OR13C9 OR11H1 OR13C2 OR10S1 OR7G3 OR11H2 OR7A10 | 1.70e-06 | 541 | 162 | 13 | 14983052 | |
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 1.96e-06 | 6 | 162 | 3 | 17635176 | |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 1.96e-06 | 6 | 162 | 3 | 18159949 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 20064729 | ||
| Pubmed | A genome-wide association study of acenocoumarol maintenance dosage. | 1.96e-06 | 6 | 162 | 3 | 19578179 | |
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 2.07e-06 | 20 | 162 | 4 | 9890157 | |
| Pubmed | Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. | 3.42e-06 | 7 | 162 | 3 | 19891553 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 20088379 | ||
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | CYP2C19 CYP2C9 MTHFD2 POLD1 CAT GSTM1 MSH6 EGF MTR AKT1 HSPB8 | 5.00e-06 | 421 | 162 | 11 | 19692168 |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 5.46e-06 | 8 | 162 | 3 | 10655549 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 6.42e-06 | 351 | 162 | 10 | 20453000 | |
| Pubmed | Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia. | 7.32e-06 | 27 | 162 | 4 | 28167773 | |
| Pubmed | 7.32e-06 | 27 | 162 | 4 | 20173083 | ||
| Pubmed | 8.16e-06 | 9 | 162 | 3 | 31491533 | ||
| Pubmed | [Analysis of genetic predisposition to pulmonary tuberculosis in native Russians]. | 8.16e-06 | 9 | 162 | 3 | 20297661 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 9.36e-06 | 219 | 162 | 8 | 12213199 | |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 1.12e-05 | 374 | 162 | 10 | 19625176 | |
| Pubmed | Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | 1.12e-05 | 161 | 162 | 7 | 36398662 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 KIF1A POLD1 MCM5 OGDH LANCL2 MSH6 PPP2R1A THADA AP1G1 RDH11 MTR PRKAR2A STIP1 POLDIP2 BSN MED23 PUM1 VCL PTCD3 | 1.15e-05 | 1425 | 162 | 20 | 30948266 |
| Pubmed | Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination. | 1.16e-05 | 10 | 162 | 3 | 23452853 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 20602612 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 22069190 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 19651758 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 20235787 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 18061941 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 19538885 | ||
| Pubmed | PP2A Inactivation Mediated by PPP2R4 Haploinsufficiency Promotes Cancer Development. | 1.16e-05 | 10 | 162 | 3 | 29046336 | |
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 1.59e-05 | 11 | 162 | 3 | 15469410 | |
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 20373852 | ||
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 15039299 | ||
| Pubmed | 2.12e-05 | 12 | 162 | 3 | 15319333 | ||
| Pubmed | Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. | 2.12e-05 | 12 | 162 | 3 | 20375710 | |
| Pubmed | 2.12e-05 | 35 | 162 | 4 | 18992148 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 26122864 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 18033814 | ||
| Pubmed | Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. | 2.16e-05 | 2 | 162 | 2 | 12435384 | |
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 2.16e-05 | 2 | 162 | 2 | 18511451 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 18694831 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21331324 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 28513222 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15385837 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 25518510 | ||
| Pubmed | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 2.16e-05 | 2 | 162 | 2 | 8333835 | |
| Pubmed | Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. | 2.16e-05 | 2 | 162 | 2 | 18006659 | |
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 2.16e-05 | 2 | 162 | 2 | 32587777 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32683556 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15855721 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 14623888 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22589111 | ||
| Pubmed | CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. | 2.16e-05 | 2 | 162 | 2 | 15660966 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 33115391 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17562299 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 36960518 | ||
| Pubmed | Beta1 integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth. | 2.16e-05 | 2 | 162 | 2 | 19633169 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 26690534 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19199010 | ||
| Pubmed | Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling. | 2.16e-05 | 2 | 162 | 2 | 22496232 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19381162 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19358898 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 34438105 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 16198656 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 2.16e-05 | 2 | 162 | 2 | 15569425 | |
| Pubmed | Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. | 2.16e-05 | 2 | 162 | 2 | 22491019 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21124868 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 20808793 | ||
| Interaction | CYP2C19 interactions | 4.24e-06 | 5 | 153 | 3 | int:CYP2C19 | |
| Cytoband | 9q31.1 | 3.48e-07 | 41 | 162 | 5 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 1.32e-04 | 137 | 162 | 5 | chr9q31 | |
| Cytoband | 10q24 | 2.60e-04 | 35 | 162 | 3 | 10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 6.69e-04 | 195 | 162 | 5 | chr10q23 | |
| GeneFamily | Olfactory receptors, family 13 | 3.47e-07 | 23 | 119 | 5 | 162 | |
| GeneFamily | Cytochrome P450 family 2 | 7.98e-05 | 35 | 119 | 4 | 1001 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.46e-04 | 16 | 119 | 3 | 14 | |
| GeneFamily | Dyneins, axonemal | 1.77e-04 | 17 | 119 | 3 | 536 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.87e-03 | 10 | 119 | 2 | 250 | |
| GeneFamily | Kelch like|BTB domain containing | 2.65e-03 | 42 | 119 | 3 | 617 | |
| CoexpressionAtlas | liver | HGD RELN CYP2C19 CYP2C8 CYP2C9 CYP2C18 GLS2 ALDH8A1 GSTM1 UGT1A1 ARSL SLC28A1 | 2.40e-05 | 419 | 141 | 12 | liver |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500 | ZDHHC2 MIOX ADAMTS2 SUN1 EDNRA TULP2 GSTM1 PPP2R1A AKT1 PUM1 VCL | 9.08e-05 | 408 | 141 | 11 | gudmap_developingGonad_P2_testes_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.39e-05 | 214 | 141 | 8 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | ZDHHC2 VGLL3 MIOX ADAMTS2 SUN1 SUSD3 KEAP1 LANCL2 EDNRA TULP2 GSTM1 PPP2R1A NFIB AKT1 PUM1 VCL | 1.04e-04 | 814 | 141 | 16 | gudmap_developingGonad_e18.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | ZDHHC2 VGLL3 CYP2C18 ADAMTS2 BCAS3 SUN1 SUSD3 KEAP1 EDNRA TULP2 GSTM1 PPP2R1A NFIB MTR AKT1 PUM1 | 1.11e-04 | 819 | 141 | 16 | gudmap_developingGonad_e16.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | ZDHHC2 VGLL3 MIOX ADAMTS2 SUN1 SUSD3 KEAP1 LANCL2 EDNRA TULP2 GSTM1 PPP2R1A NFIB AKT1 PUM1 VCL | 1.11e-04 | 819 | 141 | 16 | gudmap_developingGonad_P2_testes_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | ZDHHC2 ADAMTS3 ADAMTS2 MYO5B RGS2 EDNRA TULP2 ITPR2 GSTM1 SMPDL3B NFIB MTR HES1 PLD1 KAT6B | 1.23e-04 | 740 | 141 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-07 | 171 | 160 | 8 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-07 | 187 | 160 | 8 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.92e-07 | 197 | 160 | 8 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.92e-07 | 197 | 160 | 8 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.15e-07 | 198 | 160 | 8 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.15e-07 | 198 | 160 | 8 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.63e-07 | 200 | 160 | 8 | 69707f9576d326a06faac49701ef5cd632e760f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.63e-07 | 200 | 160 | 8 | f94381d0a3b5b81cdbb13b75fc0e4910cbd70382 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 149 | 160 | 7 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 172 | 160 | 7 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.78e-06 | 178 | 160 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | droplet-Kidney|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 180 | 160 | 7 | 7e5f497699876ac8e1ce780626c6f5a1f6f5f079 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 182 | 160 | 7 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-06 | 186 | 160 | 7 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 188 | 160 | 7 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 188 | 160 | 7 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 192 | 160 | 7 | f3133bbbf938a39062a9b1d1181003bb48174695 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 6.21e-06 | 192 | 160 | 7 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.21e-06 | 192 | 160 | 7 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | c13e2612330ca8b9a8c206e588b26025c4f5898c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.43e-06 | 193 | 160 | 7 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.43e-06 | 193 | 160 | 7 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-06 | 193 | 160 | 7 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-06 | 193 | 160 | 7 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.43e-06 | 193 | 160 | 7 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 194 | 160 | 7 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-06 | 195 | 160 | 7 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.87e-06 | 195 | 160 | 7 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-06 | 198 | 160 | 7 | b2d295e330772bd8e24da356c75564b4297ea9c5 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-06 | 198 | 160 | 7 | ce59ee3d970397eb62d6387699c6c6cd65457898 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.59e-06 | 198 | 160 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.59e-06 | 198 | 160 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 198 | 160 | 7 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-06 | 198 | 160 | 7 | 3ffaea4b44067d69f954b2bd3119c88a55ab232a | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-06 | 199 | 160 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.11e-06 | 200 | 160 | 7 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | droplet-Liver-Npc-18m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 151 | 160 | 6 | 86efabf27c264c856dca1cffacb16cef52e9863c | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 163 | 160 | 6 | 61b4e38d7bbbb031100670928e6fd4f7ea23814f | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 163 | 160 | 6 | 0b4d234bdd57d5e991f68942333ca89f70ea28df | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 163 | 160 | 6 | cc728796e52d0e6cc1198e0732370c62380e951d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | 082f62f759a0b16ab56fad6dd4c4dd70b4f18a5c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 166 | 160 | 6 | 0868f45d8d39ad39b5cee5e81ac3dd4dc512775d | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 168 | 160 | 6 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 169 | 160 | 6 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.49e-05 | 170 | 160 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.61e-05 | 171 | 160 | 6 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.24e-05 | 176 | 160 | 6 | 9a4cef3dc88f64a71b91ab4790ea19334afee3ee | |
| ToppCell | facs-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 177 | 160 | 6 | 7f58286fc8797e9bdcf8ece0849f55680905955d | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.66e-05 | 179 | 160 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.80e-05 | 180 | 160 | 6 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 181 | 160 | 6 | bec7076efe94898213a62db72d171d737949977e | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 181 | 160 | 6 | cf149b30b814cf87c9e923ef502cadf7fe4a3597 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.95e-05 | 181 | 160 | 6 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-MEP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.43e-05 | 184 | 160 | 6 | 19d61d0ab038b7e729e13a46f88b8cf31759485d | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | 978135173891c83470370a42b2801e09eb740320 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | f58922cf593f4b739f2713ef88a2ca3014f927e9 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | 10706441e7695212f95689414f31e8082b5eaf0a | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | 4bb0976a75126ad2b3deb5d2229f0716fafe200e | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.76e-05 | 186 | 160 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.76e-05 | 186 | 160 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.76e-05 | 186 | 160 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 187 | 160 | 6 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 187 | 160 | 6 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 187 | 160 | 6 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 5.93e-05 | 187 | 160 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-05 | 188 | 160 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 188 | 160 | 6 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 189 | 160 | 6 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.29e-05 | 189 | 160 | 6 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 189 | 160 | 6 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 189 | 160 | 6 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.29e-05 | 189 | 160 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.48e-05 | 190 | 160 | 6 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 190 | 160 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-05 | 190 | 160 | 6 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 6.67e-05 | 191 | 160 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.67e-05 | 191 | 160 | 6 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 6.67e-05 | 191 | 160 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.67e-05 | 191 | 160 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 160 | 6 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 160 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.87e-05 | 192 | 160 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 160 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 160 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 160 | 6 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.07e-05 | 193 | 160 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-05 | 193 | 160 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.07e-05 | 193 | 160 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.07e-05 | 193 | 160 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal-Cortical_hem|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 194 | 160 | 6 | 6f32422e1c079a2fbf0ab568e6cb8365fd627d9a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 160 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 194 | 160 | 6 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.27e-05 | 194 | 160 | 6 | 7b8fe5b702b99aac5bff7de8ac0b5cabb3235b56 | |
| Computational | Cytochrome P450. | 6.84e-06 | 14 | 101 | 4 | MODULE_106 | |
| Computational | Genes in the cancer module 135. | 7.98e-05 | 25 | 101 | 4 | MODULE_135 | |
| Drug | NADP(H | CYP2C19 CYP2C8 CYP2C9 CYP2C18 HK2 MIOX MTHFD2 SPTA1 SLCO4A1 CAT KEAP1 MCCC1 OGDH GSTM1 UGT1A1 RDH11 DHRS9 MTR AKT1 NR3C2 NOS1 | 1.31e-10 | 527 | 159 | 21 | CID000000930 |
| Drug | 4',5-dihydroxydiclofenac | 3.40e-08 | 6 | 159 | 4 | CID003052567 | |
| Drug | 3'-hydroxydiclofenac | 3.40e-08 | 6 | 159 | 4 | CID000112230 | |
| Drug | Lansoprazole | 2.26e-07 | 61 | 159 | 7 | ctd:D064747 | |
| Drug | Warfarin | CYP2C19 CYP2C9 CYP2C18 CAT UGT1A1 PPP2R1A SEPHS1 ARSL AKT1 STIP1 | 2.71e-07 | 166 | 159 | 10 | ctd:D014859 |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 2.81e-07 | 9 | 159 | 4 | ctd:C109602 | |
| Drug | sitaxsentan | 4.65e-07 | 10 | 159 | 4 | ctd:C106276 | |
| Drug | 5-hydroxydiclofenac | 1.09e-06 | 12 | 159 | 4 | CID003052566 | |
| Drug | midostaurin | 1.49e-06 | 115 | 159 | 8 | ctd:C059539 | |
| Drug | cumene hydroperoxide | 1.65e-06 | 52 | 159 | 6 | ctd:C007164 | |
| Drug | beta-NADP | CYP2C19 CYP2C8 CYP2C9 CYP2C18 HK2 MTHFD2 CAT OGDH NMNAT3 RDH11 MTR AKT1 NR3C2 NOS1 HSPB8 | 1.90e-06 | 490 | 159 | 15 | CID000000929 |
| Drug | trichloroethylene | 2.80e-06 | 88 | 159 | 7 | CID000006575 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 2.94e-06 | 15 | 159 | 4 | ctd:C586542 | |
| Drug | uracil | PUS3 CDKL2 NEIL1 POLD1 SPTA1 MCCC1 OGDH MSH6 SLC28A1 KAT6B NLRP8 | 3.15e-06 | 269 | 159 | 11 | CID000001174 |
| Drug | bufuralol | 3.31e-06 | 5 | 159 | 3 | ctd:C010831 | |
| Drug | Drugs, Chinese Herbal | CYP2C9 HK2 SPTA1 SHC4 CAT RGS2 EDNRA UGT1A1 PPP2R1A EGF GUCY2D CRTAM AKT1 HES1 STIP1 KDM7A | 3.70e-06 | 586 | 159 | 16 | ctd:D004365 |
| Drug | Glutathione | RELN CYP2C19 CYP2C8 CYP2C9 CYP2C18 CAT KEAP1 OGDH GSTM1 EGF MTR AKT1 | 5.07e-06 | 340 | 159 | 12 | ctd:D005978 |
| Drug | magnesium | PDC HK2 KIF1A MYO5B NEIL1 MTHFD2 POLD1 AMDHD1 SLCO4A1 CAT MCCC1 GRM5 OGDH ITGB1 RGS2 KYAT1 NMNAT3 MSH6 SPHK1 MTR PRKAR2A FGFR3 PLD1 NOS1 TOP3B | 5.40e-06 | 1325 | 159 | 25 | CID000000888 |
| Drug | Azamulinum | 6.49e-06 | 18 | 159 | 4 | CID003086060 | |
| Drug | D 703 | 6.49e-06 | 18 | 159 | 4 | CID000054088 | |
| Drug | Heme | 6.49e-06 | 18 | 159 | 4 | DB03014 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 6.58e-06 | 6 | 159 | 3 | ctd:C570106 | |
| Drug | AC1O5Z5L | 6.58e-06 | 6 | 159 | 3 | CID006443527 | |
| Drug | hydroxyl radicals | HGD CYP2C19 CYP2C8 CYP2C9 PUS3 CYP2C18 HK2 GLS2 MIOX MTHFD2 AMDHD1 CAT MCCC1 NMNAT3 GSTM1 PPP2R1A SEPHS1 ATP6V1G3 EGF ARSL MTR AKT1 PLD1 NOS1 MAN1B1 | 6.65e-06 | 1341 | 159 | 25 | CID000000961 |
| Drug | 5,6-epoxyeicosatrienoic acid | 8.08e-06 | 68 | 159 | 6 | CID000001778 | |
| Drug | hydroxytolbutamide | 8.18e-06 | 19 | 159 | 4 | CID000003656 | |
| Drug | 6|A-Hydroxycortisol | 8.18e-06 | 19 | 159 | 4 | CID000150985 | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 8.93e-06 | 193 | 159 | 9 | 7084_DN | |
| Drug | furafylline | 9.54e-06 | 41 | 159 | 5 | CID000003433 | |
| Drug | 1h1q | 9.57e-06 | 70 | 159 | 6 | CID000001540 | |
| Drug | 1-Butanol | 9.57e-06 | 70 | 159 | 6 | ctd:D020001 | |
| Drug | 3C etc | 1.02e-05 | 20 | 159 | 4 | CID000164045 | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A | SLCO4A1 MED13L CFLAR PRKAR2A RASL11B ZFYVE26 PARD3 KAT6B TRAPPC9 | 1.05e-05 | 197 | 159 | 9 | 1726_UP |
| Drug | methoxychlor | 1.13e-05 | 72 | 159 | 6 | CID000004115 | |
| Drug | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | 1.15e-05 | 7 | 159 | 3 | ctd:C547858 | |
| Drug | ABEn | 1.15e-05 | 7 | 159 | 3 | CID000126301 | |
| Drug | 16-O-demethylaconitine | 1.15e-05 | 7 | 159 | 3 | ctd:C486136 | |
| Drug | 5-fluorotryptamine | 1.15e-05 | 7 | 159 | 3 | ctd:C034536 | |
| Drug | trichloroacetyl chloride | 1.15e-05 | 7 | 159 | 3 | CID000006420 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 1.15e-05 | 7 | 159 | 3 | CID005486899 | |
| Drug | Diclofenac | CYP2C19 CYP2C9 MTHFD2 CMPK2 CAT MED13L FANCM ITGB1 GSTM1 UGT1A1 CFLAR EGF AKT1 KAT6B VCL | 1.17e-05 | 570 | 159 | 15 | ctd:D004008 |
| Drug | zafirlukast | 1.25e-05 | 21 | 159 | 4 | ctd:C062735 | |
| Drug | lutidinic acid | 1.25e-05 | 21 | 159 | 4 | CID000010365 | |
| Drug | sulfaphenazole | 1.36e-05 | 44 | 159 | 5 | CID000005335 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 1.82e-05 | 8 | 159 | 3 | CID006439499 | |
| Drug | torsemide | 1.82e-05 | 8 | 159 | 3 | ctd:C026116 | |
| Drug | 11-HODE | 1.82e-05 | 8 | 159 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 1.82e-05 | 8 | 159 | 3 | ctd:C040997 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 1.82e-05 | 8 | 159 | 3 | ctd:C585955 | |
| Drug | cinnamic acid | 2.18e-05 | 24 | 159 | 4 | ctd:C029010 | |
| Drug | 19-HETE | 2.32e-05 | 49 | 159 | 5 | CID006439528 | |
| Drug | Tolbutamide | 2.58e-05 | 25 | 159 | 4 | ctd:D014044 | |
| Drug | Ticlopidine | 2.58e-05 | 25 | 159 | 4 | ctd:D013988 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.67e-05 | 170 | 159 | 8 | 1631_UP | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 2.72e-05 | 9 | 159 | 3 | ctd:C545880 | |
| Drug | Acenocoumarol | 2.72e-05 | 9 | 159 | 3 | ctd:D000074 | |
| Drug | Tryptamines | 2.72e-05 | 9 | 159 | 3 | ctd:D014363 | |
| Drug | 5-chlorotryptamine | 2.72e-05 | 9 | 159 | 3 | ctd:C529169 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 2.72e-05 | 9 | 159 | 3 | ctd:C000588958 | |
| Drug | 1,4-naphthoquinone | 3.04e-05 | 26 | 159 | 4 | ctd:C035342 | |
| Drug | Manganese | HLA-DRB4 MCM5 CAT OGDH ITGB1 RGS2 DNAH14 MSH6 EGF NFIB AKT1 NOS1 MIA | 3.41e-05 | 480 | 159 | 13 | ctd:D008345 |
| Drug | licochalcone A | 3.55e-05 | 27 | 159 | 4 | ctd:C070840 | |
| Drug | 14(15)-EpETrE | 3.80e-05 | 89 | 159 | 6 | CID000001431 | |
| Drug | norketobemidone | 3.87e-05 | 10 | 159 | 3 | CID000161154 | |
| Drug | BAPTA-AM | 4.22e-05 | 293 | 159 | 10 | CID000002293 | |
| Drug | (hydrochloride) | 4.75e-05 | 29 | 159 | 4 | CID000004923 | |
| Drug | triphenylstannanylium | 4.75e-05 | 29 | 159 | 4 | CID000091481 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 4.75e-05 | 29 | 159 | 4 | CID005375667 | |
| Drug | dibenzylfluorescein | 4.85e-05 | 2 | 159 | 2 | ctd:C558664 | |
| Drug | cistinexine | 4.85e-05 | 2 | 159 | 2 | CID000065644 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 4.87e-05 | 185 | 159 | 8 | 1226_UP | |
| Drug | AC1L1BEQ | 4.87e-05 | 93 | 159 | 6 | CID000001407 | |
| Drug | silybin | 5.18e-05 | 94 | 159 | 6 | ctd:C440975 | |
| Drug | Haloperidol metabolite I | 5.29e-05 | 11 | 159 | 3 | CID000038282 | |
| Drug | Sulfinpyrazone | 5.29e-05 | 11 | 159 | 3 | ctd:D013442 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 5.29e-05 | 11 | 159 | 3 | ctd:C507866 | |
| Drug | bromoacetaldehyde | 5.30e-05 | 58 | 159 | 5 | CID000105131 | |
| Drug | fenvalerate | 6.18e-05 | 97 | 159 | 6 | ctd:C017690 | |
| Drug | aniline | 6.41e-05 | 142 | 159 | 7 | CID000006115 | |
| Drug | Ifosfamide | 6.43e-05 | 248 | 159 | 9 | ctd:D007069 | |
| Drug | BP-4,5-oxide | 6.77e-05 | 61 | 159 | 5 | CID000037786 | |
| Drug | 20-hydroxy-5,8,11,14-eicosatetraenoic acid | 7.02e-05 | 12 | 159 | 3 | ctd:C055987 | |
| Drug | 4-(N-propionylanilino)piperidine | 7.02e-05 | 12 | 159 | 3 | CID000259381 | |
| Drug | 14,15-epoxy-5,8,11-eicosatrienoic acid | 7.02e-05 | 12 | 159 | 3 | ctd:C046782 | |
| Drug | carveol | 7.02e-05 | 12 | 159 | 3 | CID000007438 | |
| Drug | desethylamodiaquine | 7.02e-05 | 12 | 159 | 3 | ctd:C047386 | |
| Drug | norclozapine | 7.02e-05 | 12 | 159 | 3 | ctd:C058272 | |
| Drug | BP-7,8-oxide | 7.07e-05 | 32 | 159 | 4 | CID000037455 | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; HL60; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 2389_UP | |
| Drug | 2 E1 | 7.32e-05 | 145 | 159 | 7 | CID006102788 | |
| Drug | AC1Q6O8T | 7.58e-05 | 197 | 159 | 8 | CID000002193 | |
| Drug | alpha-ketoglutarate | 7.72e-05 | 254 | 159 | 9 | CID000000051 | |
| Drug | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 7.72e-05 | 315 | 159 | 10 | ctd:D015632 | |
| Drug | itraconazole oral solution | 7.74e-05 | 101 | 159 | 6 | CID000003793 | |
| Drug | omeprazole | 7.74e-05 | 101 | 159 | 6 | CID000004594 | |
| Drug | 1-naphthol | 8.00e-05 | 33 | 159 | 4 | ctd:C029350 | |
| Drug | C070379 | 8.13e-05 | 199 | 159 | 8 | CID003034747 | |
| Drug | KMBA | 9.02e-05 | 34 | 159 | 4 | CID000000473 | |
| Drug | S-methylcysteine | 9.02e-05 | 34 | 159 | 4 | CID000024417 | |
| Drug | Docetaxel trihydrate | 9.02e-05 | 202 | 159 | 8 | CID000003143 | |
| Disease | X-21258 measurement | 1.42e-07 | 3 | 155 | 3 | EFO_0800802 | |
| Disease | Cleft Palate | 2.42e-07 | 81 | 155 | 7 | C0008925 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 3.87e-06 | 45 | 155 | 5 | DOID:8947 (biomarker_via_orthology) | |
| Disease | Hodgkin Disease | 4.98e-06 | 22 | 155 | 4 | C0019829 | |
| Disease | optic neuritis (is_implicated_in) | 7.81e-06 | 8 | 155 | 3 | DOID:1210 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.33e-05 | 147 | 155 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Crohn's disease (is_implicated_in) | 1.80e-05 | 30 | 155 | 4 | DOID:8778 (is_implicated_in) | |
| Disease | Non-Small Cell Lung Carcinoma | 1.95e-05 | 156 | 155 | 7 | C0007131 | |
| Disease | Depressive disorder | 2.36e-05 | 289 | 155 | 9 | C0011581 | |
| Disease | X-14473 measurement | 2.74e-05 | 2 | 155 | 2 | EFO_0021370 | |
| Disease | thymol sulfate measurement | 3.02e-05 | 12 | 155 | 3 | EFO_0021170 | |
| Disease | Hodgkin lymphoma, lymphocyte depletion | 3.91e-05 | 13 | 155 | 3 | C0152267 | |
| Disease | Mixed Cellularity Hodgkin Lymphoma | 3.91e-05 | 13 | 155 | 3 | C0152266 | |
| Disease | Lymphocyte Rich Classical Hodgkin Lymphoma | 3.91e-05 | 13 | 155 | 3 | C1266194 | |
| Disease | Adult Hodgkin Lymphoma | 3.91e-05 | 13 | 155 | 3 | C0220597 | |
| Disease | Nodular Lymphocyte Predominant Hodgkin Lymphoma | 3.91e-05 | 13 | 155 | 3 | C1334968 | |
| Disease | Amphetamine-Related Disorders | 4.81e-05 | 75 | 155 | 5 | C0236733 | |
| Disease | Amphetamine Abuse | 4.81e-05 | 75 | 155 | 5 | C0236807 | |
| Disease | Amphetamine Addiction | 4.81e-05 | 75 | 155 | 5 | C0236804 | |
| Disease | Malignant neoplasm of breast | OBSCN SUSD3 CAT KEAP1 CUBN RGS2 EDNRA MSH6 EGF SLC28A1 MTR AKT1 ZFYVE26 HES1 OCLN KAT6B NLRP8 | 5.30e-05 | 1074 | 155 | 17 | C0006142 |
| Disease | Cleft palate, isolated | 7.02e-05 | 42 | 155 | 4 | C1837218 | |
| Disease | Unipolar Depression | 7.17e-05 | 259 | 155 | 8 | C0041696 | |
| Disease | cyclo(leu-pro) measurement | 8.20e-05 | 3 | 155 | 2 | EFO_0800676 | |
| Disease | keratosis (is_implicated_in) | 8.20e-05 | 3 | 155 | 2 | DOID:161 (is_implicated_in) | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 1.03e-04 | 88 | 155 | 5 | EFO_0803332 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 1.10e-04 | 47 | 155 | 4 | DOID:783 (biomarker_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 1.48e-04 | 215 | 155 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Esophageal Achalasia | 1.63e-04 | 4 | 155 | 2 | C0014848 | |
| Disease | Idiopathic achalasia of esophagus | 1.63e-04 | 4 | 155 | 2 | C0859976 | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 1.63e-04 | 4 | 155 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | leukemia | 2.03e-04 | 55 | 155 | 4 | C0023418 | |
| Disease | lung disease (is_implicated_in) | 2.03e-04 | 22 | 155 | 3 | DOID:850 (is_implicated_in) | |
| Disease | hypertension (biomarker_via_orthology) | 2.06e-04 | 227 | 155 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | platelet reactivity measurement, response to clopidogrel | 2.33e-04 | 23 | 155 | 3 | EFO_0004985, GO_1903493 | |
| Disease | Disease Exacerbation | 2.45e-04 | 165 | 155 | 6 | C0235874 | |
| Disease | Partial Fetal Alcohol Syndrome | 2.71e-04 | 5 | 155 | 2 | C3661483 | |
| Disease | bombesin receptor-activated protein C6orf89 measurement | 2.71e-04 | 5 | 155 | 2 | EFO_0801428 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 2.71e-04 | 5 | 155 | 2 | C0814154 | |
| Disease | Keratosis Blennorrhagica | 2.71e-04 | 5 | 155 | 2 | C0022594 | |
| Disease | Keratosis | 2.71e-04 | 5 | 155 | 2 | C0022593 | |
| Disease | Keratoma | 2.71e-04 | 5 | 155 | 2 | C0086501 | |
| Disease | Major Depressive Disorder | 3.12e-04 | 243 | 155 | 7 | C1269683 | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 4.06e-04 | 6 | 155 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | Alcohol Related Birth Defect | 4.06e-04 | 6 | 155 | 2 | C3146244 | |
| Disease | Mental Depression | 4.07e-04 | 254 | 155 | 7 | C0011570 | |
| Disease | erythrocyte measurement | 4.36e-04 | 257 | 155 | 7 | EFO_0005047 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.59e-04 | 68 | 155 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | Cardiomyopathies, Primary | 4.86e-04 | 69 | 155 | 4 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 4.86e-04 | 69 | 155 | 4 | C0036529 | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 5.66e-04 | 7 | 155 | 2 | EFO_0800655 | |
| Disease | gallbladder cancer (is_marker_for) | 5.66e-04 | 7 | 155 | 2 | DOID:3121 (is_marker_for) | |
| Disease | angle-closure glaucoma (is_implicated_in) | 5.66e-04 | 7 | 155 | 2 | DOID:13550 (is_implicated_in) | |
| Disease | Cardiomyopathies | 6.33e-04 | 130 | 155 | 5 | C0878544 | |
| Disease | mucocutaneous lymph node syndrome | 7.00e-04 | 76 | 155 | 4 | EFO_0004246 | |
| Disease | urinary bladder cancer (is_implicated_in) | 7.00e-04 | 76 | 155 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | Plasmodium falciparum malaria (is_implicated_in) | 7.52e-04 | 8 | 155 | 2 | DOID:14067 (is_implicated_in) | |
| Disease | metabolite measurement | CYP2C8 CYP2C9 GLS2 SPTA1 MCCC1 KYAT1 ITPR2 UGT1A1 APIP SLC28A1 | 7.88e-04 | 560 | 155 | 10 | EFO_0004725 |
| Disease | Schizophrenia | DLGAP1 RELN ADAMTS3 MYO5B HLA-DQB1 CSMD2 GRM5 RGS2 GSTM1 MTR AKT1 NOS1 TOP3B | 8.14e-04 | 883 | 155 | 13 | C0036341 |
| Disease | endometrial cancer (is_implicated_in) | 8.94e-04 | 36 | 155 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 9.63e-04 | 9 | 155 | 2 | EFO_0600040 | |
| Disease | cholestasis (implicated_via_orthology) | 9.63e-04 | 9 | 155 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Drug toxicity | 1.02e-03 | 84 | 155 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.02e-03 | 84 | 155 | 4 | C0041755 | |
| Disease | dilated cardiomyopathy (is_marker_for) | 1.13e-03 | 39 | 155 | 3 | DOID:12930 (is_marker_for) | |
| Disease | cervix carcinoma (is_implicated_in) | 1.20e-03 | 10 | 155 | 2 | DOID:2893 (is_implicated_in) | |
| Disease | Immature Reticulocyte Fraction Measurement | 1.20e-03 | 10 | 155 | 2 | EFO_0009253 | |
| Disease | osteonecrosis (is_implicated_in) | 1.20e-03 | 10 | 155 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | breast cancer (is_implicated_in) | 1.20e-03 | 150 | 155 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | cervical cancer | 1.22e-03 | 40 | 155 | 3 | MONDO_0002974 | |
| Disease | Colorectal Carcinoma | ZDHHC2 POLD1 OBSCN CUBN GSTM1 MSH6 FOXL2 AKT1 NR3C2 FGFR3 NLRP8 | 1.26e-03 | 702 | 155 | 11 | C0009402 |
| Disease | Drug-Induced Liver Disease | 1.38e-03 | 404 | 155 | 8 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 1.38e-03 | 404 | 155 | 8 | C3658290 | |
| Disease | Hepatitis, Toxic | 1.38e-03 | 404 | 155 | 8 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 1.38e-03 | 404 | 155 | 8 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 1.38e-03 | 404 | 155 | 8 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 1.38e-03 | 404 | 155 | 8 | C1262760 | |
| Disease | autistic disorder (is_implicated_in) | 1.40e-03 | 42 | 155 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | human papilloma virus infection, oral cavity cancer | 1.40e-03 | 42 | 155 | 3 | EFO_0001668, EFO_0005570 | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 1.40e-03 | 42 | 155 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | X-11308 measurement | 1.46e-03 | 11 | 155 | 2 | EFO_0800693 | |
| Disease | senile cataract (is_implicated_in) | 1.46e-03 | 11 | 155 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 1.46e-03 | 11 | 155 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | middle temporal gyrus volume measurement | 1.46e-03 | 11 | 155 | 2 | EFO_0010316 | |
| Disease | schizophrenia (is_marker_for) | 1.61e-03 | 44 | 155 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Diabetes, Autoimmune | 1.61e-03 | 44 | 155 | 3 | C0205734 | |
| Disease | Brittle diabetes | 1.61e-03 | 44 | 155 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 1.61e-03 | 44 | 155 | 3 | C4554117 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 1.61e-03 | 44 | 155 | 3 | C3837958 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 1.61e-03 | 95 | 155 | 4 | EFO_0803331 | |
| Disease | urate measurement, bone density | CYP2C8 HCN2 OGDH DNAH14 ITPR2 C11orf96 PRKAR2A NR3C2 GPC5 KAT6B | 1.67e-03 | 619 | 155 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Diabetes Mellitus, Insulin-Dependent | 1.72e-03 | 45 | 155 | 3 | C0011854 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 1.72e-03 | 45 | 155 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | Clear Cell Meningioma | 1.75e-03 | 12 | 155 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 1.75e-03 | 12 | 155 | 2 | C1334271 | |
| Disease | Benign Meningioma | 1.75e-03 | 12 | 155 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 1.75e-03 | 12 | 155 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 1.75e-03 | 12 | 155 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 1.75e-03 | 12 | 155 | 2 | C1527197 | |
| Disease | Gastrointestinal Diseases | 1.75e-03 | 12 | 155 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 1.75e-03 | 12 | 155 | 2 | C0559031 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMVCDMKPEIHVNYR | 101 | Q96LB4 | |
| LQRYNPSMDRAQGMC | 66 | Q9HAA7 | |
| VLAMSGDPNYLHRMT | 486 | P30153 | |
| EMMCGRLPFYNQDHE | 341 | P31749 | |
| MDHLGCMHYTVRAPV | 131 | Q9H2A2 | |
| MRNHTITEQPMCFQR | 256 | P51690 | |
| YQCVPGYMMESHRVS | 2976 | Q7Z408 | |
| GYRASAHQPEMVMVL | 236 | A6NCI8 | |
| ARVANYQRDGPMCMQ | 381 | P04040 | |
| NMICLLGPSYREMHL | 571 | Q9NPI1 | |
| HGGIMDRFDCQYLMA | 376 | O95674 | |
| SPCMQDRSHMPYTDA | 336 | P10632 | |
| VMTMGRCPDRSASQY | 221 | O14490 | |
| MVPFEYRGEQHKTCM | 226 | P25101 | |
| YVNAIMQLGSIMEHC | 106 | Q9GZS0 | |
| ISCYGTLVEHMMEPR | 616 | Q9H6U6 | |
| MHGISQILGQFACMP | 286 | O15519 | |
| MQGYAPVTGMCHPVR | 376 | O95450 | |
| MQFHLMFYCTRTLPN | 136 | Q9BV10 | |
| ERRLPNTFCGENMHM | 91 | P54107 | |
| NTFCGENMHMTSYPV | 96 | P54107 | |
| HGPAMQCFLDQVAMV | 671 | Q86YV0 | |
| MMYSPICLTQDEFHP | 1 | O00712 | |
| CQIELHGEGKMMQYN | 366 | Q99650 | |
| HQLLCQYMTAAAPMQ | 361 | Q6XE24 | |
| PNDGQCHLENNMYTM | 296 | P05556 | |
| NDIYGGEMHVRPMLS | 26 | Q16625 | |
| YNDRASFPILLHMMC | 1346 | Q14571 | |
| SCIMIMPQHQRQGFG | 856 | Q8WYB5 | |
| IITMGHRPMYCSNAD | 281 | Q6ZNF0 | |
| MHMLGYPAHFGQLEC | 56 | O43747 | |
| IPFYMGMREAQNSHV | 246 | Q9Y2S7 | |
| SYNQDAMERVCMHPH | 421 | Q9Y4B6 | |
| MPEKNEHSYCTMIRG | 251 | Q96EY7 | |
| CQPLHYPVAMNRRMC | 141 | Q8NGN2 | |
| CDRRLHTPMYMFLGN | 66 | Q8NH07 | |
| GMMAFDRYVAICNPL | 116 | Q8NGS5 | |
| NVSCILTMPQYMRQG | 471 | O95251 | |
| HNLNIGMQLRCYEME | 371 | Q6ZMT4 | |
| YVQSVPRMMQDADCH | 271 | Q9H511 | |
| LHNMQMSLCPGYAGL | 411 | P41594 | |
| HQSAMYELCQGMHQI | 841 | P08235 | |
| CYTEMLDNLPEHMRN | 1706 | Q71F56 | |
| RCYGMPGMSSLQDRH | 261 | Q96FI4 | |
| VPHGEMPRHMQLYCD | 236 | P33992 | |
| MQEVVCRSAPYAMLE | 736 | Q02846 | |
| QLMMDPHCRTRIGFQ | 406 | Q9C0I1 | |
| PCENGVMLYMRNVSH | 36 | Q86W28 | |
| NVMRGCLAHMAELNP | 276 | P78333 | |
| QRVTVMRGHCHQPDM | 321 | Q4VC44 | |
| MQHVCAMRQVDIDAY | 411 | Q92485 | |
| MADGQMPFSCHYPSR | 1 | Q9UJY1 | |
| IEACYQVMGIPQSHM | 151 | Q8IYD8 | |
| CHGAPGVIHMLMQAY | 321 | Q9NS86 | |
| MCAALNSMDQYGGRH | 2101 | Q9UPA5 | |
| GTGSNACYMEEMRHI | 231 | P52789 | |
| CMEDPQRHTNKIYRM | 276 | Q58FG0 | |
| QCMQDMHQKLSFGPR | 96 | P20941 | |
| KPLHYMTIMNRETCN | 126 | Q8NH73 | |
| ACARQPELAMMHCSY | 346 | P58012 | |
| QPYSRDMVCNMLGLN | 276 | Q9ULK4 | |
| FHVSCAQAAGVMMQP | 856 | O75164 | |
| VRNTLSLMHSCGMYD | 386 | Q9UI32 | |
| MSLYTGAERPAHMCV | 336 | Q99958 | |
| NPECLKMVISGMRYH | 256 | Q8IXQ5 | |
| GMMAFDRYVAICNPL | 116 | Q8NGS9 | |
| MSHMLCIGYGQQAPV | 306 | Q9P1Z3 | |
| ITMGNIGRQLAMYEC | 201 | Q9Y5U4 | |
| YSQNVAVRLGHMACM | 1256 | P52701 | |
| CYQMNRQMETGLSPE | 556 | Q9UKM7 | |
| SLVMGCGQKYTPHMD | 931 | P78509 | |
| FGCALMEMRHPNSVQ | 826 | P29475 | |
| VCTMNDGPHSALYTM | 1101 | Q14671 | |
| PADMGVYRCLAENSM | 5191 | Q5VST9 | |
| VCYRRNGHNEMDEPM | 506 | Q02218 | |
| SDIDQLYHIMMCLGN | 206 | Q92772 | |
| GPFTHTRQCVYMMKQ | 726 | O60494 | |
| VMLEMTPQHGDVYTC | 191 | P01920 | |
| EMSYQRMENPGCHVV | 411 | Q5EBM0 | |
| MQGYAPVTGMCHPVR | 366 | O15072 | |
| HHQMGLCYRAQMIQI | 286 | Q13325 | |
| SPCMQDRGHMPYTDA | 336 | P33261 | |
| EKNGQSSHPMRCMNY | 346 | O95727 | |
| SCPQVMERSFHMPSY | 1156 | P01133 | |
| PATVSRCGMIYMEPH | 1741 | Q8WXX0 | |
| CLDENGMTPLMHAAY | 41 | Q8IV38 | |
| SGEVYTCQVEHPSMM | 196 | P13762 | |
| NMSCAVFITMNPRYG | 1231 | Q0VDD8 | |
| NPNAYCFSMPMVMHL | 336 | Q96NU7 | |
| FCFMEMNTRLQVEHP | 331 | Q96RQ3 | |
| CVLHVMNGAVMYQID | 151 | Q14145 | |
| LGPCMDIMKRNISHY | 371 | P13861 | |
| SPCMQDRSHMPYTDA | 336 | P33260 | |
| QRPRTLLCHDMMGGY | 121 | Q8NFI3 | |
| AKDSCMMVIPQAYHL | 216 | Q5T1A1 | |
| SPCMQDRSHMPYTDA | 336 | P11712 | |
| PANCTHDLYMIMREC | 716 | P22607 | |
| MMSQIHEACIGFHPY | 241 | Q8NDH6 | |
| YVNMDLSPVVECMDH | 256 | Q9BPW9 | |
| DLVHMAIQIACGMSY | 441 | P34925 | |
| MMAHNLCYTTLLRPG | 611 | P28340 | |
| AMSHMLCIGYGRQAP | 421 | Q9UL51 | |
| LVNMIMFCTGIPGHY | 336 | O94829 | |
| RHQISMAVIYPFMQG | 176 | Q9H6A0 | |
| MPCMGTFLLHQGIQR | 1161 | Q12756 | |
| CDRRLHTPMYMFLGN | 66 | Q8NG94 | |
| GMMAFDRYVAICNPL | 146 | Q8NGS6 | |
| SPREGHMMDALYAQV | 1116 | Q8TEW0 | |
| RNCMSEFMGLIRGHY | 336 | Q93099 | |
| CMTQINAMTYPGQPH | 146 | Q14469 | |
| CSHPISMAVALQDYM | 41 | Q16674 | |
| SMAVALQDYMAPDCR | 46 | Q16674 | |
| LGMYQPHCGLDRVLM | 176 | Q9UGB7 | |
| AMMAYDRFVAICHPL | 116 | Q8NGA1 | |
| GMMAFDRYVAICNPL | 116 | Q8NGT0 | |
| MMLPFCGNNVIDHIT | 196 | Q8NGV5 | |
| QCTPLFMNAYTMRGA | 96 | Q96GX9 | |
| RMAHAMNEYPDSCAV | 176 | Q96GX9 | |
| MVLQLCPVLGDHMYS | 251 | Q6P087 | |
| MPYMTREQERGHAAV | 51 | Q9BQC6 | |
| MRLIQNMCTIAEYPA | 1 | Q9BPW5 | |
| LHVLINNAGVMMCPY | 121 | Q8TC12 | |
| MQSAMFLAVQHDCRP | 1 | P41220 | |
| VLMFRCPSNHQMVGS | 56 | Q96L08 | |
| QYFAEPMMLDCGHNI | 21 | P14373 | |
| LRGMYEELNEMCHKP | 226 | P0CI25 | |
| IMRCGHSPVYHSREM | 1351 | Q6YHU6 | |
| GQAFLYHQVRCMMAI | 271 | Q9BZE2 | |
| CMMAQYNRHDSPEDV | 471 | P31948 | |
| NVGRMCLDQYSMLPA | 161 | P13995 | |
| AIMHFNYRTMCRGEN | 841 | Q13393 | |
| HYMVIMNPQLCGLLV | 131 | O76100 | |
| VMMAYDRFVAICHPL | 116 | Q8NG95 | |
| FVQFPQAMQRCRDHM | 306 | Q16773 | |
| DNHMQLGMICYNPEF | 106 | P09488 | |
| EHLAYRMNMCSAGVA | 111 | Q99707 | |
| PYMMGRIACANVLSD | 96 | P49903 | |
| PGSQRYAVMRAAEMH | 336 | Q96BD0 | |
| SFENCMSYRMSLHQP | 106 | O95561 | |
| LMGICSSYQAVMPHF | 321 | Q7Z7L8 | |
| FLQHLLGMGMNYCVR | 181 | Q6S5L8 | |
| MGPQHAMQTAERLYT | 316 | O95985 | |
| DPYMMGRIACANVLS | 146 | Q99611 | |
| LPGTMMQCYLTRDKH | 281 | O00295 | |
| ICTPLHYPNVMNMRV | 126 | Q8NGC2 | |
| HYPNVMNMRVCIQLV | 131 | Q8NGC2 | |
| LRGMYEELNEMCHKP | 226 | P0CI26 | |
| MTPVRMQHSLAGQTY | 1 | Q6VEQ5 | |
| MTPVRMQHSLAGQTY | 1 | A8K0Z3 | |
| GHRLANVMMGPYRQD | 526 | P18206 | |
| HGVYESICNGVPMVM | 376 | P22309 | |
| MTPVRMQHSLAGQTY | 1 | C4AMC7 | |
| SFCATHMQQYMDPRG | 2386 | P02549 | |
| NLCILTFGMVNPHMY | 41 | Q9NZM6 | |
| YMPRGAEVDCMSLLN | 591 | O00337 | |
| SSAVMPYPMLEHCNN | 196 | O43149 | |
| NHGRLSPQYMCEAML | 111 | Q9ULT0 | |
| PMGRCAAGVMHLFYV | 276 | Q9NYA1 | |
| MSVPDYMQCAEDHQT | 1 | Q96Q05 | |
| MENTGEQVVCLMAYH | 46 | Q9UIJ5 | |
| MDFSRLHMYSPPQCV | 1 | O94901 | |
| LRGMYEELNEMCHKP | 226 | A6NDI0 | |
| MSCAEVMYHPQPYGA | 1 | A8MV65 | |
| PTLFGNNHMKMDVAC | 2361 | Q68DK2 | |
| YMCTASNLHGLDRMV | 1926 | Q9NR99 | |
| MNAFHTVMCDQGLDP | 1661 | Q9ULV0 | |
| ACGSFNPITNMHLRM | 11 | Q96T66 |